Global Next-Generation Sequencing (NGS) Market to Reach USD 19 Billion by 2029, Driven by Technological Advancements and Expanding Applications

Mordor Intelligence has published a new report on the Next Generation Sequencing ngs Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The Next-Generation Sequencing (NGS) Market is projected to be valued at USD 10 billion in 2024 and is anticipated to grow to USD 19 billion by 2029, with a compound annual growth rate (CAGR) of 13.43% during the forecast period (2024-2029). The growing applications in clinical diagnosis, coupled with advancements in speed, cost-effectiveness, and accuracy, as well as enhanced efficiency compared to traditional technologies.

Report Overview - https://www.mordorintelligence.com/industry-reports/global-next-generation-sequencing-ngs-market-industry

Key Trends

1. Technological Innovations Enhancing Sequencing Efficiency

Recent developments in NGS technologies have led to the creation of more efficient, accurate, and cost-effective sequencing platforms. For instance, Illumina's introduction of compact, low-cost gene sequencing devices aims to make sequencing accessible to a broader range of research and testing laboratories.

2. Growing Adoption in Clinical Diagnostics

NGS is increasingly being integrated into clinical diagnostics, particularly in oncology, where it aids in identifying genetic mutations and tailoring personalized treatment plans. The technology's ability to provide comprehensive genomic profiles is revolutionizing cancer diagnostics and treatment strategies, leading to improved patient outcomes.

3. Expansion into Non-Medical Applications

Beyond healthcare, NGS is finding applications in agriculture for crop improvement and in environmental science for biodiversity studies. The technology's versatility allows for detailed genetic analysis across various organisms, contributing to advancements in fields such as agrigenomics and conservation biology.

4. Strategic Collaborations and Acquisitions

Key industry players are engaging in strategic partnerships and acquisitions to enhance their NGS capabilities. For example, Illumina's acquisition of Fluent BioSciences aims to strengthen its position in the single-cell analysis market, indicating a trend towards consolidation and expansion of service offerings within the industry.

Market Segmentation

1. By Type of Sequencing

Whole Genome Sequencing: Comprehensive analysis of entire genomes, providing extensive data for research and clinical applications.

Targeted Resequencing: Focuses on specific regions of the genome, offering cost-effective solutions for identifying known genetic variants.

Whole Exome Sequencing: Examines all coding regions of genes, aiding in the discovery of disease-associated variants.

RNA Sequencing: Analyzes gene expression patterns, crucial for understanding functional genomics.

ChIP Sequencing: Combines chromatin immunoprecipitation with sequencing to study protein-DNA interactions.

De Novo Sequencing: Assembles genomes without a reference, essential for studying novel organisms.

Methyl Sequencing: Investigates DNA methylation patterns, important for epigenetic research.

2. By Product Type

Instruments: Sequencing machines and related hardware.

Reagents and Consumables: Chemicals and materials used during sequencing processes.

Services: Data analysis, interpretation, and other support services.

3. By End User

Hospitals and Healthcare Institutions: Utilize NGS for diagnostics and personalized medicine.

Academic and Research Institutions: Employ NGS in various research projects.

Pharmaceutical and Biotechnology Companies: Use NGS in drug discovery and development.

4. By Application

Drug Discovery and Personalized Medicine: NGS aids in identifying therapeutic targets and tailoring treatments.

Genetic Screening: Detects genetic disorders and predispositions.

Diagnostics: Identifies pathogens and genetic mutations.

Agriculture and Animal Research: Enhances crop and livestock breeding programs.

Other Applications: Includes forensics and evolutionary biology studies.

5. By Geography

North America: Holds the largest market share due to advanced healthcare infrastructure and significant research activities.

Europe: Shows substantial growth driven by increasing adoption of NGS in clinical diagnostics.

Asia-Pacific: Expected to witness the fastest growth, attributed to rising investments in healthcare and biotechnology sectors.

Middle East and Africa: Emerging markets with growing interest in genomic research.

South America: Experiencing gradual adoption of NGS technologies.

Get a Customized Report Tailored to Your Requirements: - https://www.mordorintelligence.com/market-analysis/next-generation-sequencing

Key Players

The NGS market is characterized by the presence of several key players who are instrumental in driving innovation and market growth:

Illumina Inc.

Thermo Fisher Scientific Inc.

Agilent Technologies

F. Hoffmann-La Roche Ltd

PerkinElmer Inc.

These companies are actively involved in research and development, strategic collaborations, and product launches to maintain their competitive edge and meet the evolving demands of the market.

Conclusion

The global Next-Generation Sequencing market is on a robust growth trajectory, propelled by technological innovations, expanding applications across various sectors, and strategic industry collaborations. As sequencing technologies become more accessible and cost-effective, their integration into clinical diagnostics, research, and other fields is expected to deepen, offering unprecedented insights into genomics and fostering advancements in personalized medicine, agriculture, and beyond. The continuous efforts of key market players to innovate and expand their offerings will play a crucial role in shaping the future landscape of the NGS market.

Industry Related Reports

Clinical Oncology NGD Market: The Clinical Oncology NGS Market is categorized by technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges), workflow (Pre-Sequencing, Sequencing, Data Analysis), application (Screening, Companion Diagnostics, Other Diagnostics), end-use (Hospitals, Clinics, Laboratories), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/clinical-oncology-ngs-market

NGS Sample Preparation Market: The report provides a forecast for the Global NGS Sample Preparation Market, segmented by product class (Reagents and Consumables, Workstations), application (Diagnostics, Drug Discovery, and Other Applications), end user (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/ngs-sample-preparation-market

Next Generation Sequencing Informatics Market: The report explores the Next-Generation Sequencing Laboratory Informatics Market, segmented by products and services (NGS Informatics Services, Data Analysis and Management Tools, and Primary and Secondary Data Analysis Tools), application (Drug Discovery, Genetic Screening, Precision Medicine, and Other Applications), end user (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical Companies, and Other End Users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/next-generation-sequencing-informatics-market

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.